Advanced Micro Devices (AMD) reported second-quarter revenue and issued current-quarter guidance above analysts’ projections Tuesday, but shares slipped in after-hours trading. The Santa Clara, Calif.-based firm posted revenue that jumped 32% year-over-year to a record $7.67 billion, well above the $7.43 billion consensus estimate of analysts polled by Visible Alpha. Adjusted earnings per share of $0.48 matched expectations. Data Center …
Read More »Tag Archives: Outlook
Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. – Barron's
Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. Barron’s Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results CNBC Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance Yahoo Finance Pfizer Ups Profit View as Cost Cuts Offset Lack of Sales Growth Bloomberg Pfizer: Earnings Meet Pressure (Rating Upgrade) (NYSE:PFE) Seeking Alpha Source link
Read More »Transcript: New York Fed President John Williams Discusses the Economic Outlook – The Wall Street Journal
Transcript: New York Fed President John Williams Discusses the Economic Outlook The Wall Street Journal Fed’s New York president says tariff economic impact is only just starting The Business Times Fed’s Williams: Inflation expectations stay anchored breakingthenews.net Fed Williams: Labor market still solid in my view, will go into September meeting with an “open mind” Forex Factory Nick Timiraos: NY Fed’s Williams reads job …
Read More »How the New Texas Map Changes the Outlook for Control of the House – The New York Times
How the New Texas Map Changes the Outlook for Control of the House The New York Times Texas Pushes Redistricting Into an Era of ‘Maximum Warfare’ The New York Times Democrats blast GOP-proposed Texas congressional maps in redistricting showdown ABC News Texas Democrats are fundraising to potentially leave the state to block GOP-backed redistricting The Texas Tribune Republicans bet big on Latino voters in …
Read More »Moderna’s Key Patent Win Overshadowed By Gloomy Outlook
Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss, an improvement from a loss of $3.33 a year ago. The COVID-19 vaccine maker reported quarterly sales of $142 million, beating the consensus of $116.34 million. Sales fell 41% from $241 million in the same period in 2024. The decline was primarily driven by lower COVID-19 vaccine sales, …
Read More »Fluor Stock Tumbles 27% After Earnings Miss. Why Its 2025 Outlook Took a Hit. – Barron's
Fluor Stock Tumbles 27% After Earnings Miss. Why Its 2025 Outlook Took a Hit. Barron’s Why Fluor Stock Is Crashing Today Yahoo Finance Fluor plunges after wide Q2 miss, steep full-year guidance cut (FLR:NYSE) Seeking Alpha Fluor: Q2 Earnings Snapshot San Francisco Chronicle FLR Investors Have Opportunity to Join Fluor Corporation Fraud Investigation with the Schall Law Firm The Globe and Mail Source link
Read More »Novo Nordisk (NVO) Extends Fall on 3rd Day as Pessimistic Outlook Lingers
We recently published 10 Stocks Hit by Painful Plunge. Novo Nordisk A/S (NYSE:NVO) is one of the best-performing stocks on Wednesday. Novo Nordisk extended its losing streak to a third straight day on Wednesday, dropping 7.25 percent to close at $50.03 apiece after earning a stock downgrade from Bank of America. In a market note, the investment firm said it downgraded …
Read More »Fed's reticence on rate cuts forces market to rethink outlook – Reuters
Fed’s reticence on rate cuts forces market to rethink outlook Reuters Fed keeps interest rates unchanged for fifth-straight time CNN Trump’s Fight With the Fed Won’t End With Rate Cuts The New York Times Despite double dissent, Jerome Powell retains his hold on markets The Economist 2 Fed officials break ranks as Trump wages war on Powell Politico Source link
Read More »Novo Nordisk continues to slip after outlook cut, obesity drug worries (NVO:NYSE) – Seeking Alpha
Novo Nordisk continues to slip after outlook cut, obesity drug worries (NVO:NYSE) Seeking Alpha Wegovy maker Novo’s profit warning triggers $70 billion share rout Reuters Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning The New York Times NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead? Yahoo Finance Health Care Roundup: Market Talk The Wall Street Journal Source link
Read More »Microsoft’s monster quarter and strong outlook cements its status as an AI leader
Microsoft shares surged in extended trading on Wednesday after the tech giant reported strong quarterly results, fueled by an acceleration in cloud-computing revenue growth. An upbeat forecast for the current period solidified the stock’s advance. Revenue increased 18% year over year to $76.4 billion in its fiscal 2025 fourth quarter, beating the Street consensus estimate of $73.8 billion, according to …
Read More »